Twenty‐five years ago the use of Bayesian methods in Pharmaceutical R&D was non‐existent. Today that is no longer true. In this paper I describe my own personal journey along the road of discovery of Bayesian methods to routine use in the pharmaceutical industry.
No takes yet. Share an insight, caveat, or question.
Andrew P. Grieve (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: